Activity Overview | This Webcast contains video and downloadable slides from “Triple-Negative Breast Cancer: On the Pathway to Better Outcomes,” a ESMO Milan 2010 Satellite Symposium. |
Faculty | Chair
Ian Smith, MD, FRCP, FRCPE
Royal Marsden Hospital
London, United Kingdom
Faculty
Nadia Harbeck, MD, PhD
University of Cologne
Cologne, Germany
John E. Pippen, Jr, MD, FACP
US Oncology
Baylor Sammons Cancer Center
Dallas, Texas, United States
Giuseppe Viale, MD, PhD
European Institute of Oncology and University of Milan
Milan, Italy |
Target Audience | This educational activity is designed for medical oncologists, radiation oncologists, surgical oncologists, pathologists and other healthcare providers involved and/or interested in the management of patients with breast cancer. |
|
|
 |
|
Expert Discussion
|
 |
|
Downloadable Slides
|
|
 |
Topics |
Understanding the biology of triple-negative breast cancer (TNBC)
Giuseppe Viale, MD, PhD |
Triple-negative breast cancer: What we know and what we don’t know
Nadia Harbeck, MD, PhD |
PARP inhibition: Why it works in TNBC
John E. Pippen, Jr, MD, FACP |
|
|
|
|
Support | This activity is supported by
sanofi-aventis
 |
|
